Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years

Author(s):
Adachi, J.D.; Lin, C.J.F.; Ho, P.R.; Bolognese, M.A.; Bone, H.G.; Hadji, P.; Papapoulos, S.; Recknor, C.; Daizadeh, N.S.; Dakin, P.; Wagman, R.B.; Ferrari, S.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S981-S981
hdl
1887/103097